Home › Science › Science Evaluates In Vivo Cell Enginee
SCIENCE
Science Evaluates In Vivo Cell Engineering in Autoimmune Disease
Research published in Science examines whether in-body cell engineering can treat autoimmune diseases.
By Xentir Media Newsroom · Editorial standards by Jomon · September 04, 2026 · 1 min read
WHAT YOU NEED TO KNOW
Science published reporting on in-body cell genetic engineering on September 3, 2026.
The publication evaluates whether engineered cells can combat autoimmune diseases.
The work is indexed under DOI 10.1126/science.zppekgo.
Science published reporting on September 3, 2026, addressing whether cells genetically engineered directly inside the body can combat autoimmune diseases.
The journal registered the publication under digital object identifier 10.1126/science.zppekgo at 01:50 UTC.
Xentir Media NewsroomSource-backed AI and technology coverage, drafted by Xentir's automated editorial system under fixed human-set rules. See our editorial policy and AI usage policy.
Jomon · Founder & EditorFounder and editor of Xentir Media. Sets the editorial rules the newsroom system runs under, and is accountable for its corrections. About Jomon · [email protected]
The Xentir Brief The developments worth knowing — one useful email. Get the Brief →
